United States · 
Who invested in Protiva Biotherapeutics?
Protiva Biotherapeutics's investors include BDC Capital, GrowthWorks, Canadian Medical Discoveries Fund and Kinetic Capital.
2007
$5.0MSeries C$3.3MSeries DUnited States · Series D startup
Who invested in Protiva Biotherapeutics
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$8.3Mraised across 2 rounds since 2006, from 2 sources
$5.0MSeries C$3.3MSeries D
- Latest round
- Series D, $3.3MJul 2007
- Biggest round
- $5.0MSeries C · Jul 2006
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series C, $5.0M Jul 2006
- Biggest round
- $5.0M Series C · Jul 2006
- Between rounds
- 12 months from the last two
The rounds
- Jul 2007Series D$3.3M3 returning
From a historical funding record
- Jul 2006Series C$5.0M4 new
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
The exit
ExitBuyerPriceWhen
AcquiredTekmira Pharmaceuticals$32MMar 2008
From historical deal records. Wrong? Tell us.
Everyone who backed them
GrowthWorksVC firm2rounds
Canadian Medical Discoveries FundVC firm2rounds
Missing a round, or an investor who was in one? Tell us.
Quick answers about Protiva Biotherapeutics
How much has Protiva Biotherapeutics raised?
Protiva Biotherapeutics has raised $8.3M across 2 rounds since 2006.
When did Protiva Biotherapeutics last raise?
Protiva Biotherapeutics's most recent round was a Series D of $3.3M in Jul 2007.
What was Protiva Biotherapeutics's biggest round?
Protiva Biotherapeutics's largest round on record is $5.0M (Series C), in Jul 2006.
Who backed Protiva Biotherapeutics first?
Protiva Biotherapeutics's first round on record, in Jul 2006, was backed by BDC Capital, GrowthWorks and Canadian Medical Discoveries Fund and 1 others.
What stage is Protiva Biotherapeutics at?
Protiva Biotherapeutics's latest named round is a Series D, in Jul 2007.
Where is Protiva Biotherapeutics based?
Protiva Biotherapeutics is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.